600329.SH
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 40.46
−0.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 30.07x
- P/E 2027E
- 26.17x
- P/E 2028E
- 23.57x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.62x
- PEG TTM
- 0.54x
- Price / book
- 5.24x
- Price / sales
- 6.24x
- Price / cash flow
- 58.81x
Enterprise value
- Enterprise value
- CNY 30.2B
- EV / sales
- 6.06x
- EV / EBITDA
- 11.56x
- EV / EBIT
- 11.86x
- Market cap
- CNY 31.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026